Huntsman (NYSE:HUN – Get Free Report) issued its quarterly earnings data on Monday. The basic materials company reported ($0.25) earnings per share for the quarter, missing the consensus estimate of ($0.07) by ($0.18), Zacks reports. Huntsman had a negative return on equity of 0.03% and a negative net margin of 1.99%. The business had revenue of $1.45 billion during the quarter, compared to analyst estimates of $1.45 billion.
Huntsman Trading Up 2.1 %
Shares of HUN traded up $0.38 during trading hours on Wednesday, hitting $18.18. 537,840 shares of the stock were exchanged, compared to its average volume of 2,802,897. Huntsman has a fifty-two week low of $15.67 and a fifty-two week high of $27.01. The company has a debt-to-equity ratio of 0.45, a current ratio of 1.47 and a quick ratio of 0.83. The business has a 50-day moving average of $17.52 and a 200-day moving average of $20.19. The firm has a market capitalization of $3.14 billion, a P/E ratio of -26.29 and a beta of 0.95.
Huntsman Announces Dividend
The company also recently disclosed a quarterly dividend, which will be paid on Monday, March 31st. Stockholders of record on Friday, March 14th will be given a dividend of $0.25 per share. This represents a $1.00 annualized dividend and a dividend yield of 5.50%. Huntsman’s dividend payout ratio (DPR) is presently -144.93%.
Analysts Set New Price Targets
Check Out Our Latest Report on Huntsman
Huntsman Company Profile
Huntsman Corporation manufactures and sells diversified organic chemical products worldwide. The company operates in three segments: Polyurethanes, Performance Products, and Advanced Materials. The Polyurethanes segment offers polyurethane chemicals, including methyl diphenyl diisocyanate, polyether and polyester polyols, and thermoplastic polyurethane; and aniline, benzene, nitrobenzene and other co-products.
Featured Stories
- Five stocks we like better than Huntsman
- What is a Secondary Public Offering? What Investors Need to Know
- Intel Surges on M&A Talks: Rally Beginning or Just a Headfake?
- 3 Stocks to Protect Your Portfolio from the Coronavirus Contagion
- Solid Biosciences Soars 32% on Trial Data: 189% Upside from Here?
- 3 Small Caps With Big Return Potential
- Up Nearly 1000%, Can AppLovin Keep Delivering for Investors?
Receive News & Ratings for Huntsman Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Huntsman and related companies with MarketBeat.com's FREE daily email newsletter.